{"id":"W2606172910","doi":"10.1093/rheumatology/kex061","title":"Rheumatoid arthritis oral abstractsO01. Efficacy and Safety of Baricitinib Versus Placebo and Adalimumab in Patients with Moderately to Severely Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Summary Results from the 52-Week Phase 3 RA-Beam Study","year":2017,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Eli Lilly (Canada)","funders":"","keywords":"Medicine; Rheumatoid arthritis; Adalimumab; Methotrexate; Placebo; Internal medicine; Dermatology; Antirheumatic Agents; Arthritis; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00237755,0.001701921,0.002736282,0.000446117,0.0004796297,0.001074864,0.0006428316,0.001197858,0.0145985],"category_scores_gemma":[0.00182823,0.0005403447,0.002024203,0.0005381608,0.0002842517,0.0003494787,0.0002495029,0.002041591,0.002711702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006114749,"about_ca_system_score_gemma":0.001019799,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001058137,"about_ca_topic_score_gemma":0.002041305,"domain_scores_codex":[0.9992598,0.0003546391,0.00008784641,0.00007021469,0.0001380767,0.00008954691],"domain_scores_gemma":[0.9985114,0.0003350651,0.0005549605,0.00004792993,0.0001894147,0.0003612774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7801026,0.005679202,0.003543201,0.008172266,0.005165206,0.0001930573,0.0000815753,0.0002935536,0.008191129,0.0001430643,0.0394492,0.1489858],"study_design_scores_gemma":[0.7964835,0.1380043,0.03809948,0.0006762343,0.004081987,0.0003312919,0.0000470619,0.0003501894,0.001856525,0.0001446763,0.01987581,0.00004895615],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5719906,0.3293903,0.002152282,0.006366129,0.004294245,0.01109406,0.04244408,0.0007607711,0.03150754],"genre_scores_gemma":[0.8601491,0.07235958,0.002583158,0.006638525,0.004058199,0.006946755,0.02205973,0.0001111196,0.02509388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0145985,"threshold_uncertainty_score":0.04883683,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02765569010870534,"score_gpt":0.3027008002447219,"score_spread":0.2750451101360166,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}